Antioxidants,
Год журнала:
2023,
Номер
12(10), С. 1845 - 1845
Опубликована: Окт. 11, 2023
Several
studies
report
that
breast
cancer
survivors
(BCS)
tend
to
have
a
poor
diet,
as
fruit,
vegetable,
and
legume
consumption
is
often
reduced,
resulting
in
decreased
intake
of
nutraceuticals.
Moreover,
weight
gain
has
been
commonly
described
among
BCS
during
treatment,
increasing
recurrence
rate
mortality.
Improving
lifestyle
nutrition
after
the
diagnosis
BC
may
important
benefits
on
patients’
general
health
specific
clinical
outcomes.
The
Mediterranean
diet
(MD),
known
for
its
multiple
beneficial
effects
health,
can
be
considered
nutritional
pool
comprising
several
nutraceuticals:
bioactive
compounds
foods
with
anti-inflammatory
antioxidant
effects.
Recent
scientific
advances
led
identification
nutraceuticals
could
amplify
MD
favorably
influence
gene
expression
these
patients.
Nutraceuticals
postdiagnostic
phase
BC,
including
helping
mitigate
adverse
chemotherapy
radiotherapy.
valid
easy-to-follow
option
managing
excess
weight.
aim
this
narrative
review
evaluate
recent
literature
possible
consuming
functional
nutraceutical
framework
BCS.
Nutrients,
Год журнала:
2023,
Номер
15(21), С. 4639 - 4639
Опубликована: Ноя. 1, 2023
Taste
disorders
are
common
among
cancer
patients
undergoing
chemotherapy,
with
a
prevalence
ranging
from
20%
to
86%,
persisting
throughout
treatment.
This
condition
leads
reduced
food
consumption,
increasing
the
risk
of
malnutrition.
Malnutrition
is
associated
not
only
worse
treatment
efficacy
and
poor
disease
prognosis
but
also
functional
status
quality
life.
The
fruit
Synsepalum
dulcificum
(Daniell),
commonly
known
as
miracle
berry
or
fruit,
contains
miraculin,
taste-modifying
protein
profound
effects
on
taste
perception.
CLINMIR
Protocol
triple-blind,
randomized,
placebo-controlled
clinical
trial
designed
evaluate
regular
consumption
supplement
containing
miraculin-based
novel
food,
dried
(DMB),
perception
(measured
through
electrogustometry)
nutritional
(evaluated
GLIM
Criteria)
malnourished
under
active
antineoplastic
To
this
end,
pilot
study
was
30
randomized
divided
into
three
arms
(150
mg
DMB
+
150
freeze-dried
strawberries,
300
DMB,
placebo)
for
months.
Throughout
five
main
visits,
an
exhaustive
assessment
different
parameters
susceptible
improvement
will
be
conducted,
including
electrical
chemical
perception,
smell
morphofunctional
assessment,
diet,
life,
fatty
acid
profile
erythrocytes,
levels
inflammatory
cancer-associated
cytokines,
oxidative
stress,
antioxidant
defense
system,
plasma
metabolomics,
saliva
stool
microbiota.
primary
anticipated
result
that
distortion
who
consume
report
in
translates
increased
intake,
thereby
ameliorating
their
mitigating
risks.
Additionally,
aims
pinpoint
optimal
dosage
provides
maximal
benefits.
protocol
adheres
SPIRIT
2013
Statement,
which
evidence-based
recommendations
widely
endorsed
international
standard
protocols.
has
been
registered
at
platform
Clinical
Trials
(NCT05486260).
Experimental Oncology,
Год журнала:
2024,
Номер
45(4), С. 504 - 514
Опубликована: Фев. 3, 2024
Background.
The
development
of
human
breast
cancer
(BC)
is
known
to
be
closely
related
disturbances
in
the
mammary
gland
microbiota.
Bacteria
genus
Bifidobacterium
are
an
important
component
normal
microbiota
and
exert
antitumor
activity.
molecular-biological
mechanisms
interaction
between
BC
cells
members
remain
poorly
studied
yet.
aim
this
study
was
develop
optimize
experimental
model
system
for
co-cultivation
with
animalis
vitro.
Materials
Methods.
Human
ВС
MCF-7,
T47D,
MDA-MB-231
lines,
as
well
live
heat-inactivated
bacteria
subsp.
lactis
(B.
animalis)
were
used
research
objects.
growth
kinetics
viability
B.
presence
different
cell
lines
without
them
determined
by
both
turbidimetry
method
seeding
on
elective
nutrient
medium.
Glucose
consumption
lactate
production
bifidobacteria
assessed
biochemical
methods.
a
standard
colorimetric
method.
Results.
complete
DMEM
medium
showed
patterns.
indicators
glucose
confirm
its
physiological
metabolic
activity
under
conditions.
did
not
affect
duration
phases
cells’
population
but
contributed
increase
their
counts.
A
significant
decrease
number
all
observed
only
after
48
h
animalis.
To
achieve
similar
suppression
viability,
10—30-fold
higher
counts
heatinactivated
required
compared
ones.
Conclusions.
optimal
conditions
living
vitro
have
been
identified.
Abstract
The
gut
microbiota
has
been
demonstrated
to
be
correlated
with
the
clinical
phenotypes
of
diseases,
including
cancers.
However,
there
are
few
studies
on
subtyping
based
microbiota,
especially
in
breast
cancer
(BC)
patients.
Here,
using
machine
learning
methods,
we
analysed
BC,
colorectal
(CRC),
and
gastric
(GC)
patients
identify
their
shared
metabolic
pathways
importance
these
development.
Based
microbiota-related
pathways,
human
gene
expression
profile
patient
prognosis,
established
a
novel
BC
system
identified
subtype
called
“challenging
BC”.
Tumours
this
have
more
genetic
mutations
complex
immune
environment
than
those
other
subtypes.
A
score
index
was
proposed
for
in-depth
analysis
showed
significant
negative
correlation
prognosis.
Notably,
activation
TPK1-FOXP3-mediated
Hedgehog
signalling
pathway
TPK1-ITGAE-mediated
mTOR
linked
poor
prognosis
BC”
high
scores,
as
validated
patient-derived
xenograft
(PDX)
model.
Furthermore,
our
effective
predictors
response
current
neoadjuvant
therapy
regimens,
significantly
negatively
both
treatment
efficacy
number
cells.
Therefore,
findings
provide
valuable
insights
into
predicting
molecular
characteristics
responses
Frontiers in Microbiology,
Год журнала:
2024,
Номер
15
Опубликована: Май 27, 2024
Background
The
relationship
between
gut
microbiota
and
breast
cancer
has
been
extensively
studied;
however,
changes
in
after
surgery
are
still
largely
unknown.
Materials
methods
A
total
of
20
patients
with
underwent
routine
open
at
the
First
Affiliated
Hospital
Hainan
Medical
College
from
1
June
2022
to
December
2022.
Stool
samples
were
collected
undergoing
mastectomy
for
preoperatively,
3
days
later,
7
later
postoperatively.
stool
subjected
16s
rRNA
sequencing.
Results
Surgery
did
not
affect
α-diversity
microbiota.
β-diversity
composition
microorganisms
significantly
affected
by
patients.
Both
linear
discriminant
analysis
effect
size
(LEfSe)
between-group
differences
showed
that
led
a
decrease
abundance
Firmicutes
Lachnospiraceae
an
increase
Proteobacteria
Enterobacteriaceae
.
Moreover,
127
differential
metabolites
screened
classified
into
5
categories
based
on
their
changing
trends.
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
enrichment
significant
phenylalanine
metabolic
pathway
exogenous
substance
pathway.
Eight
characterized
using
ROC
analysis.
Conclusion
Our
study
found
altered
metabolites,
beneficial
bacteria
potentially
harmful
bacteria.
This
underscores
importance
enhanced
postoperative
management
optimize
Antioxidants,
Год журнала:
2023,
Номер
12(10), С. 1845 - 1845
Опубликована: Окт. 11, 2023
Several
studies
report
that
breast
cancer
survivors
(BCS)
tend
to
have
a
poor
diet,
as
fruit,
vegetable,
and
legume
consumption
is
often
reduced,
resulting
in
decreased
intake
of
nutraceuticals.
Moreover,
weight
gain
has
been
commonly
described
among
BCS
during
treatment,
increasing
recurrence
rate
mortality.
Improving
lifestyle
nutrition
after
the
diagnosis
BC
may
important
benefits
on
patients’
general
health
specific
clinical
outcomes.
The
Mediterranean
diet
(MD),
known
for
its
multiple
beneficial
effects
health,
can
be
considered
nutritional
pool
comprising
several
nutraceuticals:
bioactive
compounds
foods
with
anti-inflammatory
antioxidant
effects.
Recent
scientific
advances
led
identification
nutraceuticals
could
amplify
MD
favorably
influence
gene
expression
these
patients.
Nutraceuticals
postdiagnostic
phase
BC,
including
helping
mitigate
adverse
chemotherapy
radiotherapy.
valid
easy-to-follow
option
managing
excess
weight.
aim
this
narrative
review
evaluate
recent
literature
possible
consuming
functional
nutraceutical
framework
BCS.